Outpatient parenteral antibiotic therapy. Management of serious infections. Part I: Medical, socioeconomic, and legal issues. Selecting the antibiotic

scientific article

Outpatient parenteral antibiotic therapy. Management of serious infections. Part I: Medical, socioeconomic, and legal issues. Selecting the antibiotic is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1080/21548331.1993.11442930
P698PubMed publication ID8505393

P2093author name stringCraig WA
P2860cites workDeterminants of efficacy and toxicity of aminoglycosidesQ34510814
Continuous-infusion ampicillin therapy of enterococcal endocarditis in ratsQ35536118
Continuous infusion of beta-lactam antibioticsQ35656806
Pharmacokinetics and bactericidal rates of daptomycin and vancomycin in intravenous drug abusers being treated for gram-positive endocarditis and bacteremiaQ35836523
Correlation of various in vitro testing methods with clinical outcomes in patients with Bacteroides fragilis group infections treated with cefoxitin: a retrospective analysisQ35867013
Once-daily aminoglycoside therapyQ37730823
Enhancing effect of serum ultrafiltrate on the activity of cephalosporins against gram-negative bacilliQ39814757
Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal modelQ43617611
Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentrationQ44483617
Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infectionsQ54297609
Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation.Q54319060
Penicillin resistance and defective lysis in clinical isolates of pneumococci: evidence for two kinds of antibiotic pressure operating in the clinical environment.Q54383172
P921main subjectantibioticQ12187
socioeconomicsQ1643441
P304page(s)16-20
P577publication date1993-06-01
P1433published inHospital practice (Office ed.)Q27711433
P1476titleOutpatient parenteral antibiotic therapy. Management of serious infections. Part I: Medical, socioeconomic, and legal issues. Selecting the antibiotic
P478volume28 Suppl 1

Reverse relations

cites work (P2860)
Q33938974Ambulatory use of parenteral antibacterials: contemporary perspectives
Q40526811Antibiotic kinetics and dynamics for the clinician.
Q40432517Antibiotic selection factors and description of a hospital-based outpatient antibiotic therapy program in the USA
Q40459002Beta-Lactam Antibiotics: Is Continuous Infusion The Preferred Method of Administration?
Q28375792Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis
Q35627814Delivering antibacterials to the lungs: considerations for optimizing outcomes.
Q80967238Infusion phlebitis: relative incidence associated with cefuroxime administered by intermittent and continuous infusion
Q33539736Interrelationship between pharmacokinetics and pharmacodynamics in choosing the appropriate antibiotic and the dosage regimen for treating acute exacerbations of chronic bronchitis.
Q30426113Intravenous antimicrobial therapy in the community: underused, inadequately resourced, or irrelevant to health care in Britain?
Q72582713Is it time to redefine the management of febrile neutropenia in cancer patients?
Q45927552Pharmacokinetics and pharmacodynamics of newer oral cephalosporins: implications for treatment of community-acquired lower respiratory tract infections.
Q37557851Pharmacological rationale for antibiotic treatment of intra-abdominal infections
Q40284867Retain intermittent dosing of carbapenems

Search more.